vivo NEX 3 is powered by the Qualcomm SDM855 Snapdragon 855+ Octa-core (1×2.96 GHz Kryo 485 + 3×2.42 GHz Kryo 485 + 4×1.8 GHz Kryo 485) processor. The smartphone comes with a 6.89 inches Super AMOLED ...

The biggest stories of the day delivered to your inbox.

VIVO has come out with a 72-hour flash sale offer (Aug 7 to 9) where anyone can buy the smartphone at Rs 1947 on the occasion of Independence Day online at shop.vivo.com/in ...

Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...

Awaiting FDA clinical hold letter on MAGNITUDE and MAGNITUDE-2 clinical trials of nex-zPresenting longer-term Phase 1 ...

Intellia Therapeutics has acknowledged the death of the elderly patient hospitalized last week in its Phase III trial of assessing nexiguran ziclumeran (nex-z) in transthyretin amyloidosis with ...

Intellia Therapeutics (NTLA) stock plummets after the company's Q3 updates indicate a patient deeath in a Phase 3 for its nex ...

Intellia Therapeutics also has fans on Wall Street. The company's current average price target of $32.3 (according to Yahoo!

A patient dosed with Intellia Therapeutics’ CRISPR gene therapy has died after suffering a severe liver-associated adverse ...

Despite a narrower Q3 loss, NTLA stock plunges after pulling nex-z milestone guidance amid FDA scrutiny in amyloidosis patients.

A patient dosed in the MAGNITUDE study has suffered a Grade 4 liver transaminases and increased total bilirubin.

Intellia Therapeutics stock crashed Friday after a patient in its gene-editing study died following serious increases in liver enzymes.